Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

CD151 represses mammary gland development by maintaining the niches of progenitor cells

Producción científica: Articlerevisión exhaustiva

15 Citas (Scopus)

Resumen

Tetraspanin CD151 interacts with laminin-binding integrins (i.e., a3b1, a6b1 and a6b4) and other cell surface molecules to control diverse cellular and physiological processes, ranging from cell adhesion, migration and survival to tissue architecture and homeostasis. Here, we report a novel role of CD151 in maintaining the branching morphogenesis and activity of progenitor cells during the pubertal development of mammary glands. In contrast to the disruption of laminin-binding integrins, CD151 removal in mice enhanced the tertiary branching in mammary glands by 2.4-fold and the number of terminal end buds (TEBs) by 30%, while having minimal influence on either primary or secondary ductal branching. Consistent with these morphological changes are the skewed distribution of basal/ myoepithelial cells and a 3.2-fold increase in proliferating Ki67-positive cells. These novel observations suggest that CD151 impacts the branching morphogenesis of mammary glands by upregulating the activities of bipotent progenitor cells. Indeed, our subsequent analyses indicate that upon CD151 removal the proportion of CD24HiCD49fLow progenitor cells in the mammary gland increased by 34%, and their proliferating and differentiating activities were significantly upregulated. Importantly, fibronectin, a pro-branching extracellular matrix (ECM) protein deposited underlying mammary epithelial or progenitor cells, increased by 7.2-fold. Moreover, there was a concomitant increase in the expression and nuclear distribution of Slug, a transcription factor implicated in the maintenance of mammary progenitor cell activities. Taken together, our studies demonstrate that integrin-associated CD151 represses mammary branching morphogenesis by controlling progenitor cell activities, ECM integrity and transcription program.

Idioma originalEnglish
Páginas (desde-hasta)2707-2722
Número de páginas16
PublicaciónCell Cycle
Volumen13
N.º17
DOI
EstadoPublished - sept 1 2014

Nota bibliográfica

Publisher Copyright:
© 2014 Taylor &Francis Group, LLC.

Financiación

This study was supported in part through DOD Award (W81XWH-07–1–0568), Susan G. Komen For The Cure Career Catalyst Award (KG081481), NIH COBRE/pilot project fund and pilot study award from the American Cancer Society (IRG 85–001–25) to X. H. Yang, RO1 (CA125454) to B. P. Zhou, and R01 (CA109136) to K. L. O’Connor.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)
U.S. Department of DefenseW81XWH-07–1–0568
American Cancer Society-Michigan Cancer Research FundCA109136, IRG 85–001–25
National Childhood Cancer Registry – National Cancer InstituteR01CA125454
Susan G. Komen for the CureKG081481

    ASJC Scopus subject areas

    • Molecular Biology
    • Developmental Biology
    • Cell Biology

    Huella

    Profundice en los temas de investigación de 'CD151 represses mammary gland development by maintaining the niches of progenitor cells'. En conjunto forman una huella única.

    Citar esto